论文部分内容阅读
目的:探讨经尿道前列腺汽化电切术治疗前列腺增生症的临床疗效和常见并发症。方法:回顾性分析113例经尿道前列腺汽化电切术患者的治疗效果和并发症发生情况。结果:经尿道前列腺汽化电切术后随访12个月,患者国际前列腺症状评分(IPSS)3~16分,平均(8.13±2.32)分。生活质量评分(QOL)0~4分,平均(1.38±0.47)分,均较术前有明显改善(P<0.05)。并发症发生率18.58%,其中继发出血2例,经尿道电切综合征(TURS)3例,尿路感染9例,尿失禁6例,排尿困难1例。结论:经尿道前列腺汽化电切术治疗前列腺增生症疗效较为理想,可通过严格掌握手术适应证、提高技术操作水平可进一步减少并发症的发生。
Objective: To investigate the clinical efficacy and common complications of transurethral vaporization of the prostate in the treatment of benign prostatic hyperplasia. Methods: A retrospective analysis of 113 cases of transurethral resection of the prostate in patients with the treatment effect and complications. Results: After 12 months of transurethral resection of the prostate, the International Prostate Symptom Score (IPSS) ranged from 3 to 16 points (mean, 8.13 ± 2.32). Quality of life scores (QOL) ranged from 0 to 4, with an average of (1.38 ± 0.47) points, which were significantly improved compared with those before operation (P <0.05). Complication rate was 18.58%. Among them, 2 were secondary hemorrhage, 3 were TURS, 9 were urinary tract infection, 6 were urinary incontinence and 1 was dysuria. Conclusion: Transurethral electrovaporization of the prostate for the treatment of benign prostatic hyperplasia is more effective. It can further reduce the incidence of complications by strictly observing the indication of operation and improving the technical operation level.